Search hospitals

>

Colorado

>

Colorado Springs

Penrose-Saint Francis Healthcare

Claim this profile

Colorado Springs, Colorado 80907

Global Leader in Breast Cancer

Global Leader in Lung Cancer

Conducts research for Breast cancer

Conducts research for Non-Small Cell Lung Cancer

Conducts research for Cancer

316 reported clinical trials

3 medical researchers

Photo of Penrose-Saint Francis Healthcare in Colorado SpringsPhoto of Penrose-Saint Francis Healthcare in Colorado SpringsPhoto of Penrose-Saint Francis Healthcare in Colorado Springs

Summary

Penrose-Saint Francis Healthcare is a medical facility located in Colorado Springs, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Penrose-Saint Francis Healthcare is involved with conducting 316 clinical trials across 437 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.

Area of expertise

1

Breast Cancer

Global Leader

Penrose-Saint Francis Healthcare has run 53 trials for Breast Cancer. Some of their research focus areas include:

HER2 negative
Stage IV
ER positive
2

Lung Cancer

Global Leader

Penrose-Saint Francis Healthcare has run 52 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage I

Top PIs

Clinical Trials running at Penrose-Saint Francis Healthcare

Bladder Cancer

Lung Cancer

Breast Cancer

Prostate Cancer

Breast cancer

Ovarian Cancer

Esophageal cancer

Multiple Myeloma

Colorectal Cancer

Bladder Carcinoma

Image of trial facility.

Gemcitabine + Docetaxel vs BCG

for Bladder Cancer

This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.

Recruiting

2 awards

Phase 3

14 criteria

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

Recruiting

2 awards

Phase 3

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Penrose-Saint Francis Healthcare?

Where is Penrose-Saint Francis Healthcare located?

Who should I call to ask about financial aid or insurance network?

What insurance does Penrose-Saint Francis Healthcare accept?

What awards or recognition has Penrose-Saint Francis Healthcare received?